Eslicarbazepine Use During Breastfeeding: A Case Report of Two Infants

A case report documents successful breastfeeding by a mother with drug-resistant epilepsy treated with eslicarbazepine acetate, with measured infant serum drug levels at 9.1% and 7.5% of maternal concentration and no adverse effects at 13 months follow-up. The authors conclude that breastfeeding may be considered under clinical supervision for healthy term infants of mothers on eslicarbazepine monotherapy, while noting that safety data remain limited.